Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...

"It's criminal to put someone on a GLP-1 and not put them on a dietary plan," says Phil Vella, founder of Vita Bella Health, ...

There’s a perception that Ozempic, Wegovy and Zepbound are all you need to live a healthier life. But diet and exercise still ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

Semaglutide led to a 7.5-point overall improvement (P < .001) for KCCQ-CSS. In patients who did and did not have aFib, the difference in KCCQ-CSS was significant: 11.5 vs 4.3 points, respectively ...

More information: Busch, C.B.E, et al. Durable effects of duodenal ablation using electroporation combined with semaglutide to eliminate insulin therapy in patients with type-2 diabetes; the 24 ...

At baseline, participants had an eGFR at least 25 mL/min/1.73 m 2 with urine albumin-to-creatinine ratio (UACR) between 30 mg/g and 3,500 mg/g and BMI of 27 kg/m 2 or greater.

Of the 710 patients with type 2 diabetes (median 59 years; 52% female), 194 were on semaglutide and 516 were on a non-GLP-1 antidiabetic (e.g., insulin, metformin, sulfonylureas, α-glucosidase ...